The Impact of Named Patient Programs on Global Health
The Named Patient Programs is a unique pathway for patients and doctors to access medicines that are either not available or not approved in their home country. Even with improvements…
What Is a Comparator Drug and Why Do Clinical Trials Need It?
A comparator drug is an existing approved medicine, or sometimes a placebo, that a new investigational drug is tested against in a clinical trial. In this guide, we explain what…
Ikris Pharma Network Bulgaria: A Trusted Provider of Named Patient Programs
In the complex landscape of global healthcare, access to essential medicines is a critical issue, especially for patients who require treatments that are not yet approved in their home countries.…
